Loading…
An ouabain-like factor is secreted from immortalized hypothalamic cells in an aldosterone-dependent manner
► Brain ouabain is a key in blood pressure regulation upon excess sodium intake. ► Ouabain is produced by immortalized N1 cells, which are of hypothalamic origin. ► Aldosterone augments ouabain release in cultured N1 cells. ► Ouabain release is blocked by eplerenone, a mineralocorticoid receptor blo...
Saved in:
Published in: | Neurochemistry international 2011-08, Vol.59 (2), p.104-108 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | ► Brain ouabain is a key in blood pressure regulation upon excess sodium intake. ► Ouabain is produced by immortalized N1 cells, which are of hypothalamic origin. ► Aldosterone augments ouabain release in cultured N1 cells. ► Ouabain release is blocked by eplerenone, a mineralocorticoid receptor blocker. ► Thus, there is aldosterone-regulated secretion of ouabain by the hypothalamus.
Ouabain-like factor (OLF) modulates blood pressure via sodium pump inhibition in the central nervous system and in the peripheral circulation. Ouabain-like factor (OLF) is thought to be produced in the adrenal gland and hypothalamus, and it may relate locally to the renin–angiotensin–aldosterone system. However, the evidence for the latter was obtained from in vivo experiments using animals. In the present study, we investigated ouabain production in the immortalized hypothalamic cell line N1. First, cell culture supernatant was collected from the immortalized hypothalamic cell line N1 at 0.5, 4, 8, and 24h. A newly developed enzyme-linked immunosorbent assay (ELISA) that used anti-ouabain antibody showed that immunoreactivity in the supernatant was increased significantly at 24 vs. 0.5h (0.01±0.004 vs. 0.16±0.033pmol/mg protein, p |
---|---|
ISSN: | 0197-0186 1872-9754 |
DOI: | 10.1016/j.neuint.2011.04.019 |